Abcuro

Drug Discovery · Newton, MA · Founded 2015 · Privately Held (backing)

Developer of immunomodulatory therapeutics designed for treating both autoimmunity and cancer. Abcuro is based in Newton, MA and was founded in 2015. It was valued at $700 million at its later-stage round in Feb 2025, the last priced event on record. It has raised $407 million across 5 recorded rounds; the latest was a $200 million Series C in Feb 2025.

PMV mark · valuation
$700.0M
Oct 2026
Priced at
its later-stage round
Feb 2025
Total raised
$407.3M
Last round
Later Stage VC (Series C)
Feb 2025
How much has Abcuro raised?
$407.3Macross 5 recorded rounds · Nov 2016 – Feb 2025

Most recently, Abcuro raised $200.0M in its Later Stage VC (Series C) (Feb 2025).

Free account
More of Abcuro with a free account
  • ·The complete investor list: 20 names
  • ·Watch Abcuro: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Abcuro round by round

5 rounds
Feb 2025Later Stage VC (Series C)$200.0M▮
+ 1 more investors · free account
Aug 2023Later Stage VC (Series B)$155.0M▮
+ 1 more investors · free account
Jun 2020Early Stage VC$15.5MSEC filing▮
15 investors participated
Nov 2018Early Stage VC$8.0MSEC filing▮
3 investors participated
Nov 2016Seed Round$2.3MSEC filing▮
4 investors participated

How much has Abcuro raised?

Abcuro has raised $407 million across 5 recorded rounds since 2016. The largest was an $8 million early-stage round in Nov 2018; the most recent was a $200 million Series C in Feb 2025.

Abcuro has filed 6 Form Ds with the SEC since 2016, most recently in Feb 2025 ($80 million sold to 21 investors).

Abcuro investors

20 investors are on record for Abcuro, including RA Capital Management, New Enterprise Associates, BlackRock and Foresite Capital. By type, the record holds 5 venture capital firms, 2 private equity firms and 1 asset manager. The Series C in Feb 2025 drew 13 investors.

For fundraisers
Raising for a company like Abcuro?

20 investors have backed Abcuro — start your target list with the firms already writing checks in drug discovery.

See all 20 investors →

Frequently asked about Abcuro

How much has Abcuro raised?
Abcuro has raised $407.3M in total across 5 recorded funding rounds.
When was Abcuro's last funding round?
Abcuro's most recent recorded round was Later Stage VC (Series C) in Feb 2025, raising $200.0M.